EAGLE is an international multicentre pragmatic randomised controlled trial
New approach to management of patients with primary angle-closure glaucoma
Augusto Azuara-Blanco
Published: Thursday, September 1, 2016
EARLY EXTRACTION
It is likely that many people with PACG will go on to develop cataracts and require surgery due to ageing and the effect of conventional glaucoma treatment, which may accelerate cataract progression - but by this stage irreversible glaucoma damage and sight loss may have occurred. It is proposed that early clear lens extraction will improve glaucoma control by opening the drainage angle. This should reduce the need for medications and trabeculectomy, maintain good visual acuity, and improve quality-of-life compared with standard care. It will also improve the visual function in patients with hypermetropia (found in the majority of PACG patients), by correcting this refractive error. The hypothesis tested in the EAGLE trial was that those randomised to early lens extraction would have a higher EQ-5D score, lower IOP, and lower trabeculectomy rate than those randomised to standard care at three years. Recruitment took place in centres in the UK, East Asia and Australia. Patients were newly diagnosed with either: 1) PACG; or 2) primary angle-closure (PAC) and with IOP>30mmHg at diagnosis. They were phakic in the affected eye and 50 years or older.COMPLICATION RISKS
Patients were excluded if they had advanced glaucoma, i.e. visual field loss (mean deviation worse than -15dB), or cup-disc-ratio >0.9; previous attack of angle closure; increased surgical risk: e.g. corneal opacity, Fuch’s endothelial dystrophy; pseudoexfoliation; previous vitreoretinal surgery; not able to be positioned to undergo standard technique; symptomatic cataract in either eye; previous LI; axial length A total of 419 participants were randomised in equal proportion to lens extraction or LI and followed for three years. Surgeons involved in the study were all experienced in glaucoma and cataract surgery. The results of the EAGLE trial will be published in the near future in The Lancet, but we provide a brief summary of the results that were presented at the recent 12th European Glaucoma Society Congress. In brief, the group of participants who underwent lens extraction had better quality-of-life compared with those who underwent LI, and this was also associated with better glaucoma control (lower IOP, less number of medications and less glaucoma surgery). However, there is a risk of complications, particularly posterior capsule rupture, which was observed in about one per cent of participants undergoing lens extraction. The possibility of surgical complications in people with clear lens and good vision warrants an individualised approach and careful discussion of risks and benefits. The results of the EAGLE study are not generalizable to other people with e.g. narrow angles or primary angle-closure suspects. EAGLE was funded by MRC and managed by NIHR on behalf of the MRC-NIHR Partnership. The views expressed in this publication are those of the author and not necessarily those of the MRC, NHS, NIHR or the Department of Health * Augusto Azuara-Blanco PhD, FRCS(Ed), FRCOphth is Professor of Ophthalmology, Queen's University Belfast, Northern Ireland, and Honorary NHS Consultant Ophthalmologist, BHSCT Institute of Clinical Sciences, Belfast. He can be reached at: a.azuara-blanco@qub.ac.ukTags: lens extraction, primary angle-closure glaucoma
Latest Articles
Glaucoma Treatment Under Pressure
New techniques and technologies add to surgeons’ difficult decisions
Outside the Box, Inside the Pipeline
Researchers are tackling glaucoma diagnosis and treatment from all sides.
The EHDS Is Ready for the Green Light
If proposal is approved, Europe could see better access to, and exchange and use of, health data.
ESCRS to Release Guidelines for Cataract and Refractive Surgery
Comprehensive approach to the safest and most effective modern surgery.
Barry Fellowship Opens Up ‘Whole New Field of Thought’
The 2022 recipient combines theoretical and practical to learn new treatments.
Digitalising the OR—Experience and Perspectives
Benefits include saving time and improving outcomes.
Dynamic Measures Needed for Quality of Vision
Functional visual acuity testing and straylight metering may better reflect real-world conditions.
What Is Stopping Digital OR Adoption?
Ophthalmologists know the benefits—now it’s time to construct the right plan.
Time to Move Beyond Monofocal IOLs?
European surgeons appear hesitant to first offer other presbyopia-correcting options to patients.